FOLH1 and prostate carcinoma: A similar ligand, 3p-C-NETA-ePSMA-16, which contains a PSMA targeting vector (Scheme 10C), was also evaluated (PSMA is a highly restricted prostate epithelial cell integral membrane glycoprotein expressed in most of prostate carcinomas [142]).